Home Other Building Blocks 2-(4-((2,5-Difluorobenzyl)oxy)phenoxy)-5-ethoxyaniline

2-(4-((2,5-Difluorobenzyl)oxy)phenoxy)-5-ethoxyaniline

CAS No.:
223104-29-8
Catalog Number:
AG00BF4L
Molecular Formula:
C21H19F2NO3
Molecular Weight:
371.3773
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1mg
≥98%
1 week
United States
$111
- +
2mg
99%
1 week
United States
$133
- +
5mg
99%
1 week
United States
$173
- +
10mg
99%
1 week
United States
$265
- +
50mg
99%
1 week
United States
$682
- +
100mg
99%
1 week
United States
$1098
- +
Product Description
Catalog Number:
AG00BF4L
Chemical Name:
2-(4-((2,5-Difluorobenzyl)oxy)phenoxy)-5-ethoxyaniline
CAS Number:
223104-29-8
Molecular Formula:
C21H19F2NO3
Molecular Weight:
371.3773
MDL Number:
MFCD07772188
IUPAC Name:
2-[4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline
InChI:
InChI=1S/C21H19F2NO3/c1-2-25-18-8-10-21(20(24)12-18)27-17-6-4-16(5-7-17)26-13-14-11-15(22)3-9-19(14)23/h3-12H,2,13,24H2,1H3
InChI Key:
YSUBLPUJDOWYDP-UHFFFAOYSA-N
SMILES:
CCOc1ccc(c(c1)N)Oc1ccc(cc1)OCc1cc(F)ccc1F
Properties
Complexity:
434  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
371.133g/mol
Formal Charge:
0
Heavy Atom Count:
27  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
371.384g/mol
Monoisotopic Mass:
371.133g/mol
Rotatable Bond Count:
7  
Topological Polar Surface Area:
53.7A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.8  
Literature
Title Journal
Axonal protection achieved by blockade of sodium/calcium exchange in a new model of ischemia in vivo. Neuropharmacology 20120901
Revisiting the ionic mechanisms of early afterdepolarizations in cardiomyocytes: predominant by Ca waves or Ca currents? American journal of physiology. Heart and circulatory physiology 20120415
Molecular and functional characterization of the human platelet Na(+) /Ca(2+) exchangers. British journal of pharmacology 20120201
SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease. Neuropharmacology 20111201
The specific Na(+)/Ca(2+) exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells. Neurochemistry international 20110801
Dual inhibition of sodium-mediated proton and calcium efflux triggers non-apoptotic cell death in malignant gliomas. Brain research 20101202
KB-R7943 inhibits Na+-dependent Mg2+ efflux in rat ventricular myocytes. The journal of physiological sciences : JPS 20101101
Pathophysiological remodeling of mouse cardiac myocytes expressing dominant negative mutant of neuron restrictive silencing factor. Circulation journal : official journal of the Japanese Circulation Society 20101101
Knockout of Na+/Ca2+ exchanger in smooth muscle attenuates vasoconstriction and L-type Ca2+ channel current and lowers blood pressure. American journal of physiology. Heart and circulatory physiology 20100501
I(Ks) restricts excessive beat-to-beat variability of repolarization during beta-adrenergic receptor stimulation. Journal of molecular and cellular cardiology 20100101
Cerebral ischemia elicits aberration in myocardium contractile function and intracellular calcium handling. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20100101
Assessing manganese efflux using SEA0400 and cardiac T1-mapping manganese-enhanced MRI in a murine model. NMR in biomedicine 20091001
Involvement of protein kinase C in the regulation of Na+/Ca2+ exchanger in bovine adrenal chromaffin cells. Clinical and experimental pharmacology & physiology 20090701
Role of Na+/Ca2+ exchanger-mediated Ca2+ entry in pressure-induced myogenic constriction in rat posterior cerebral arteries. Journal of pharmacological sciences 20090601
Involvement of the Na(+)/Ca(2+) exchanger in the automaticity of guinea-pig pulmonary vein myocardium as revealed by SEA0400. Journal of pharmacological sciences 20090501
A Na+/Ca2+ exchanger isoform, NCX1, is involved in retinal cell death after N-methyl-D-aspartate injection and ischemia-reperfusion. Journal of neuroscience research 20090301
Potential therapeutic effects of Na+/Ca2+ exchanger inhibition in cardiac diseases. Current medicinal chemistry 20090101
Inhibition of the Na+/Ca2+ exchanger suppresses torsades de pointes in an intact heart model of long QT syndrome-2 and long QT syndrome-3. Heart rhythm 20081001
Antiarrhythmic benefits of targeting the Na+/Ca2+ exchanger. Heart rhythm 20081001
Burst emergence of intracellular Ca2+ waves evokes arrhythmogenic oscillatory depolarization via the Na+-Ca2+ exchanger: simultaneous confocal recording of membrane potential and intracellular Ca2+ in the heart. Circulation research 20080829
SEA0400 fails to alter the magnitude of intracellular Ca2+ transients and contractions in Langendorff-perfused guinea pig heart. Naunyn-Schmiedeberg's archives of pharmacology 20080701
Pharmacological inhibition of na/ca exchange results in increased cellular Ca2+ load attributable to the predominance of forward mode block. Circulation research 20080606
The ins and outs of calcium in heart failure. Circulation research 20080606
The Na+/Ca2+ exchange blocker SEA0400 fails to enhance cytosolic Ca2+ transient and contractility in canine ventricular cardiomyocytes. Cardiovascular research 20080601
Na(+)/Ca(2+) exchanger inhibition exerts a positive inotropic effect in the rat heart, but fails to influence the contractility of the rabbit heart. British journal of pharmacology 20080501
Intracellular mechanisms and receptor types for endothelin-1-induced positive and negative inotropy in mouse ventricular myocardium. Naunyn-Schmiedeberg's archives of pharmacology 20080201
Effect of partial blockade of the Na(+)/Ca(2+)-exchanger on Ca(2+) handling in isolated rat ventricular myocytes. European journal of pharmacology 20071208
S1P1-selective agonist SEW2871 exacerbates reperfusion arrhythmias. Journal of cardiovascular pharmacology 20071201
Mechanisms of endothelin-1-induced decrease in contractility in adult mouse ventricular myocytes. British journal of pharmacology 20071001
Negative inotropic effects of endothelin-1 in mouse cardiomyocytes: evidence of a role for Na+-Ca2+ exchange. British journal of pharmacology 20071001
[Molecular pharmacologic approaches to functional analysis of new biological target molecules for drug discovery]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20071001
Preservation of mitochondrial function may contribute to cardioprotective effects of Na+/Ca2+ exchanger inhibitors in ischaemic/reperfused rat hearts. British journal of pharmacology 20070801
Monensin causes transient calcium ion influx into mouse splenic lymphocytes in a sodium ion-independent fashion. European journal of pharmacology 20070430
Interaction between Na+/K+-pump and Na+/Ca2+-exchanger modulates intercellular communication. Circulation research 20070413
[Na+/Ca2+ exchanger (NCX1) and cardiovascular disease]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20070401
Involvement of Na+-Ca2+ exchanger in cAMP-mediated relaxation in mice aorta: evaluation using transgenic mice. British journal of pharmacology 20070201
Involvement of the Na+/Ca2+ exchanger in ouabain-induced inotropy and arrhythmogenesis in guinea-pig myocardium as revealed by SEA0400. Journal of pharmacological sciences 20070201
SEA0400, a novel Na+/Ca2+ exchanger inhibitor, reduces calcium overload induced by ischemia and reperfusion in mouse ventricular myocytes. Physiological research 20070101
Anesthetic preconditioning enhances Ca2+ handling and mechanical and metabolic function elicited by Na+-Ca2+ exchange inhibition in isolated hearts. Anesthesiology 20060901
Inhibition by SEA0400, a selective inhibitor of Na+/Ca2+ exchanger, of Na+ -dependent Ca2+ uptake and catecholamine release in bovine adrenal chromaffin cells. Journal of pharmacological sciences 20060901
Reduction by SEA0400 of myocardial ischemia-induced cytoplasmic and mitochondrial Ca2+ overload. European journal of pharmacology 20060814
Quantitative fluorescence measurement of cardiac Na+/Ca2+ exchanger inhibition by kinetic analysis in stably transfected HEK293 cells. Journal of pharmacological sciences 20060801
Cardioprotection via activation of protein kinase C-delta depends on modulation of the reverse mode of the Na+/Ca2+ exchanger. Circulation 20060704
Hypertension, Na+/Ca2+ exchanger, and Na+, K+-ATPase. Kidney international 20060601
Sodium-dependent recovery of ionised magnesium concentration following magnesium load in rat heart myocytes. Pflugers Archiv : European journal of physiology 20060201
A selective inhibitor of Na+/Ca2+ exchanger, SEA0400, preserves cardiac function and high-energy phosphates against ischemia/reperfusion injury. Journal of cardiovascular pharmacology 20060201
[Na+/Ca2+ exchanger(NCX1) and salt-sensitive hypertension]. Nihon rinsho. Japanese journal of clinical medicine 20060101
Sodium calcium exchange as a target for antiarrhythmic therapy. Handbook of experimental pharmacology 20060101
Salt-sensitive hypertension, Na+/Ca2+ exchanger, and vascular smooth muscle. Trends in cardiovascular medicine 20051101
Effects of SEA0400 and KB-R7943 on Na+/Ca2+ exchange current and L-type Ca2+ current in canine ventricular cardiomyocytes. Naunyn-Schmiedeberg's archives of pharmacology 20050701
Cardioprotection without cardiosuppression by SEA0400, a novel inhibitor of Na+-Ca2+ exchanger, during ischemia and reperfusion in guinea-pig myocardium. Life sciences 20050603
SEA-0400, a potent inhibitor of the Na+/Ca2+ exchanger, as a tool to study exchanger ionic and metabolic regulation. American journal of physiology. Cell physiology 20050601
Unique excitation-contraction characteristics of mouse myocardium as revealed by SEA0400, a specific inhibitor of Na+-Ca2+ exchanger. Naunyn-Schmiedeberg's archives of pharmacology 20050601
Therapeutic potential of novel Na+-Ca2+ exchange inhibitors in attenuating ischemia-reperfusion injury. The Canadian journal of cardiology 20050501
SEA0400, a specific inhibitor of the Na+-Ca2+ exchanger, attenuates sodium nitroprusside-induced apoptosis in cultured rat microglia. British journal of pharmacology 20050301
Functional proteins involved in regulation of intracellular Ca(2+) for drug development: pharmacology of SEA0400, a specific inhibitor of the Na(+)-Ca(2+) exchanger. Journal of pharmacological sciences 20050301
Effects of SEA0400, a Na+/Ca2+ exchange inhibitor, on ventricular arrhythmias in the in vivo dogs. European journal of pharmacology 20050104
Selective inhibition of sodium-calcium exchanger by SEA-0400 decreases early and delayed after depolarization in canine heart. British journal of pharmacology 20041201
Effects of SEA0400, a novel inhibitor of the Na+/Ca2+ exchanger, on myocardial stunning in anesthetized dogs. European journal of pharmacology 20041128
Inhibitory profile of SEA0400 [2-[4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline] assessed on the cardiac Na+-Ca2+ exchanger, NCX1.1. The Journal of pharmacology and experimental therapeutics 20041101
Salt-sensitive hypertension is triggered by Ca2+ entry via Na+/Ca2+ exchanger type-1 in vascular smooth muscle. Nature medicine 20041101
Hypertension with a grain of salt. Nature medicine 20041101
Forefront of Na+/Ca2+ exchanger studies: molecular pharmacology of Na+/Ca2+ exchange inhibitors. Journal of pharmacological sciences 20040901
Functional role of the Na+/H+ exchanger in the regulation of cerebral arteriolar tone in rats. Journal of neurosurgery 20040801
Effects of sodium-calcium exchange inhibitors, KB-R7943 and SEA0400, on aconitine-induced arrhythmias in guinea pigs in vivo, in vitro, and in computer simulation studies. The Journal of pharmacology and experimental therapeutics 20040701
Na+/Ca2+ exchange inhibitors: potential drugs to mitigate the severity of ischemic injury. Molecular pharmacology 20040701
The potential of Na+/Ca2+ exchange blockers in the treatment of cardiac disease. Expert opinion on investigational drugs 20040601
Cardioprotective effect of SEA0400, a selective inhibitor of the Na(+)/Ca(2+) exchanger, on myocardial ischemia-reperfusion injury in rats. Journal of pharmacological sciences 20040601
The selective Na+-Ca2+ exchange inhibitor attenuates brain edema after radiofrequency lesion in rats. European journal of pharmacology 20040412
Development and application of Na+/Ca2+ exchange inhibitors. Molecular and cellular biochemistry 20040401
Effects of SEA0400 on mutant NCX1.1 Na+-Ca2+ exchangers with altered ionic regulation. Molecular pharmacology 20040301
Molecular determinants of Na+/Ca2+ exchange (NCX1) inhibition by SEA0400. The Journal of biological chemistry 20040227
SEA0400: a novel sodium-calcium exchange inhibitor with cardioprotective properties. Cardiovascular drug reviews 20040101
Discovery of a novel potent Na+/Ca2+ exchanger inhibitor: design, synthesis and structure-activity relationships of 3,4-dihydro-2(1H)-quinazolinone derivatives. Bioorganic & medicinal chemistry letters 20031020
A novel and selective Na+/Ca2+ exchange inhibitor, SEA0400, improves ischemia/reperfusion-induced renal injury. European journal of pharmacology 20031008
Differing cardioprotective efficacy of the Na+/Ca2+ exchanger inhibitors SEA0400 and KB-R7943. American journal of physiology. Heart and circulatory physiology 20030301
Protective effects of SEA0400, a novel and selective inhibitor of the Na+/Ca2+ exchanger, on myocardial ischemia-reperfusion injuries. European journal of pharmacology 20030101
[Functional analysis of Na+/Ca2+ exchanger using novel drugs and genetically engineered mice]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20021101
Knockout mice for pharmacological screening: testing the specificity of Na+-Ca2+ exchange inhibitors. Circulation research 20020726
Effect of SEA0400, a novel inhibitor of sodium-calcium exchanger, on myocardial ionic currents. British journal of pharmacology 20020301
SEA0400, a novel and selective inhibitor of the Na+-Ca2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models. The Journal of pharmacology and experimental therapeutics 20010701
Order and disorder at hospital meetings. Dimensions in health service 19751201
Properties